Stay updated on Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial page.

Latest updates to the Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedClinicalTrials.gov’s page footer revision label was updated from v3.5.2 to v3.5.3, reflecting an interface/system release rather than a change to the study record.SummaryDifference0.1%

- Check16 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No other content changes are reflected in additions or deletions.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedRevision updated to v3.5.0. The previous version v3.4.3 was removed.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision: v3.4.2 was added; the notice about government funding interruptions and the prior Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check88 days agoChange DetectedA site-wide notice about government funding and NIH operations was added, and the page shows a new revision label (v3.4.1) replacing the previous (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial page.